Transgenic mouse models and human neurodegenerative disorders

Archives of Neurology

Volumn 57, Issue 12, 2000, Pages 1695-1702

  Deng, H X ^a   Siddique, T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DEGENERATIVE DISEASE; GENE TARGETING; GENOME; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; TECHNIQUE; TRANSGENIC MOUSE;

EID: 0033667504     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.12.1695     Document Type: Conference Paper

References (36)

1. Transgenic mice: A decade of progress in technology and research
2. Transgenic technology: An introduction
3. Conditional mutagenesis in mice: The Cre/IoxP recombination system
4. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
5. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
6. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
7. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
8. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
9. Inhibition of ICE slows ALS in mice
10. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
11. Lack of apoptosis in mice with ALS
12. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
13. Pathogenesis of two axonopathies does not require axonal neurofilaments
14. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant
15. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
16. Expanding our understanding of polyglutamine diseases through mouse models
17. Exon 1 of the H D gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
18. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation
19. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat
20. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
21. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
22. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice
23. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
24. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
25. Skeletal and CNS defects in presenilin-1-deficient mice
26. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
27. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyioid beta-protein in both transfected cells and transgenic mice
28. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
29. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
30. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein
31. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric humanmouse prion protein
32. Mice devoid of PrP are resistant to scrapie
33. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology
34. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene
35. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions